Clarient, Inc. (NASDAQ: CLRT)

Clarient, Inc. (NASDAQ: CLRT) is focused on providing services, resources and critical information that improve the quality of life of patients, while reducing the cost of patient care. Pathologists, oncologists, hospitals and biopharmaceutical companies are the company’s primary customers. Clarient’s state-of-the-art commercial cancer laboratory provides the most sophisticated oncology testing and drug development services available both onsite and over the web. For further information, visit the Company’s web site at www.clarientinc.com.